Crossject, a specialty pharma company developing needle-free autoinjectors for emergency situations, announces a significant improvement in its ESG Gaïa rating, achieving a score of 73/100.
Crossject, a specialty pharma company developing needle-free autoinjectors for emergency situations, announces a significant improvement in its ESG Gaïa rating, achieving a score of 73/100.